Supernus Pharmaceuticals, Inc. (SUPN)
46.50
+0.34
(+0.73%)
USD |
NASDAQ |
Dec 11, 16:00
46.50
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Research and Development Expense (TTM): 104.86M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.524B |
| BridgeBio Pharma, Inc. | 465.89M |
| CorMedix, Inc. | 12.46M |
| Assembly Biosciences, Inc. | 61.75M |
| Viking Therapeutics, Inc. | 222.48M |